²é¿´: 1390  |  »Ø¸´: 14

lovelhw

½ð³æ (³õÈëÎÄ̳)

[ÇóÖú] ¹òÇó°ïÎÒ·­ÒëÒ»ÏÂÕâ¶ÎÎÄ×Ö£¬Ö°³ÆÂÛÎļ±ÐèÒª

Ä¿µÄ  ¹Û²ì°¢Íз¥ËûÍ¡ÁªºÏ°¢Ë¹Æ¥ÁÖÖÎÁÆÔ­·¢ÐÔ¸ßѪѹºÏ²¢¾±¶¯ÂöÖàÑùÓ²»¯°ß¿éµÄÁÆÐ§¡£·½·¨  ´æÔÚ¾±¶¯ÂöÖàÑùÓ²»¯°ß¿éµÄÔ­·¢ÐÔ¸ßѪѹ»¼Õß60Àý£¬Ëæ»ú·ÖΪ¶ÔÕÕ×é×é30Àý£¬¸øÓèµ¥Óð¢Ë¹Æ¥ÁÖÆ¬£¬ÖÎÁÆ×é30Àý£¬¸øÓè°¢Íз¥ËûÍ¡ÁªºÏ°¢Ë¹Æ¥ÁÖ£»ÖÎÁÆÇ°¼°ÖÎÁƺó1¡¢3¡¢6Ô²ⶨ»¼ÕßÈýõ£¸ÊÓÍ(TG)¡¢ÑªÇå×ܵ¨¹Ì´¼(CH)¡¢µÍÃܶÈÖ¬µ°°×µ¨¹Ì´¼(LDL¡ªC)¡¢ÈéËáÍÑÇâø(LDH)ºÍ¾±¶¯ÂöÄÚÖÐĤºñ¶È(IMT)¡¢°ß¿é»ý·ÖµÄ±ä»¯¡£½á¹û ÖÎÁÆ6¸öÔºóÈýõ£¸ÊÓÍ(TG)¡¢×ܵ¨¹Ì´¼(TC)¡¢ÑªÇå×ܵ¨¹Ì´¼(CH)¡¢µÍÃܶÈÖ¬µ°°×µ¨¹Ì´¼(LDL¡ªC)¡¢°ß¿é»ý·ÖºÍ¾±¶¯ÂöÄÚÖÐĤºñ¶È(IMT)¡¢·Ö±ðΪ(2.05ÍÁ0.9)mmol£¯L  ½áÂÛ °¢Íз¥ËûÍ¡ÁªºÏ°¢Ë¹Æ¥ÁÖ£¬¶ÔËõС¾±¶¯ÂöÖàÑù°ß¿éÌå»ý¡¢Îȶ¨°ß¿é¡¢½µµÍѪ֬¸÷ÏîÖ¸±êÓнϺõÄЧ¹û£¬¿É×÷Ϊԭ·¢ÐÔ¸ßѪѹºÏ²¢¾±¶¯ÂöÖàÑùÓ²»¯°ß¿éÖÎÁƵÄÁªºÏÒ©Îï¡£

» ²ÂÄãϲ»¶

ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

befair

Ìú¸Ëľ³æ (ÕýʽдÊÖ)

¡¾´ð°¸¡¿Ó¦Öú»ØÌû

ÄãºÃ£¬¿´Äã±È½Ï׿±£¬µ«ÒòΪ²»ÊÇÕâ¸öרҵµÄ£¬ÕâÀïµÄרҵ´Ê»ãÌ«¶à£¬·­ÆðÀ´ÄÑÒÔרҵ¡£Èç¹ûÄ㻹ÐèÒª°ïÖúµÄ»°£¬¿É·ñÏȸø³öרҵ´Ê»ã£¬´ó¼Ò¿ÉÒÔ°ïÖúÄã×éÖ¯Æð½á¹¹À´£¿
Befairorbeaware
2Â¥2013-10-25 20:19:03
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

lovelhw

½ð³æ (³õÈëÎÄ̳)

°¢Íз¥ËûÍ¡Atorvastatin         °¢Ë¹Æ¥ÁÖAspirin         Ô­·¢ÐÔ¸ßѪѹprimary hypertension
¾±¶¯ÂöÖàÑùÓ²»¯°ß¿éCarotid atherosclerotic lesions            Èýõ£¸ÊÓÍtriglyceride   
ѪÇå×ܵ¨¹Ì´¼cholesteol    µÍÃܶÈÖ¬µ°°×µ¨¹Ì´¼low density lipoprotein-cholesterol
ÈéËáÍÑÇâølactate dehydrogenase            ¾±¶¯ÂöÄÚÖÐĤºñ¶ÈIntima-media thickness
°ß¿é»ý·Öcrouse score        ÑªÖ¬blood fat         ¸Ð¼¤¸÷λ´óÏÀ£¡£¡£¡
3Â¥2013-10-26 10:19:32
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

befair

Ìú¸Ëľ³æ (ÕýʽдÊÖ)

¡¾´ð°¸¡¿Ó¦Öú»ØÌû

¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ...
°®ÓëÓêÏÂ: ½ð±Ò+1 2013-11-16 06:03:08
lovelhw(phu_grassman´ú·¢): ½ð±Ò+50, you're always so kind 2014-01-16 15:55:52
lovelhw(phu_grassman´ú·¢): ½ð±Ò+25, thanks 2014-01-16 15:56:02
Objectives: To observe effectiveness of using atorvastatin in combination with aspirin for primary hypertension complicated by carotid atherosclerotic lesions.
Methodology: The 60 patients of primary hypertension with carotid atherosclerotic lesions are randomly put into a control group of 30 patients who are prescribed  aspirin only, and a treatment group of 30 patients who are prescribed atorvastatin and aspirin. Prior to the treatment and one, three and six months after it,  the patients are tested for their TG, CH, LDL-C, LDH, IMT and crouse score, in particular the changes.
Results: Six months after the treatment, all the TG, TC, CH, LDL-C, IMT values are (2.05ÍÁ0.9)mmol£¯L
Conclusions: Atorvastatin in combination with aspirin is effective for reducing volume of carotid atherosclerotic lesions, stabalising the crouse and reducing blood fat as well as other indices. Hence it can be used as a drug combination for treatment of  primary hypertension with carotid atherosclerotic lesions.
½á¹ûÒ»¾ä£º Ô­ÎÄ˵ÄÇЩָ±ê¶¼·Ö±ðÊÇ (2.05ÍÁ0.9)mmol£¯L£¬ ÄÇô¾ÍÊÇ˵ËüÃǶ¼ÊÇ (2.05ÍÁ0.9)mmol£¯L£¿»¹ÊÇËüÃÇ·Ö±ðÊÇA£¬ B£¬ C,¡£¡£¡£ÇëÈ·ÈÏ
·Ç±¾×¨Òµ£¬½ö¹©²Î¿¼
Befairorbeaware
4Â¥2013-10-26 16:22:37
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

lovelhw

½ð³æ (³õÈëÎÄ̳)

ÊÇA£¬ B£¬ C,¡£¡£¡£
5Â¥2013-10-26 20:37:25
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

befair

Ìú¸Ëľ³æ (ÕýʽдÊÖ)

¡¾´ð°¸¡¿Ó¦Öú»ØÌû

ÄãµÄÒâ˼ÊÇA=B=C=(2.05ÍÁ0.9)mmol£¯L£¿
Befairorbeaware
6Â¥2013-10-26 22:53:14
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

lovelhw

½ð³æ (³õÈëÎÄ̳)

·Ö±ðΪ(2.05ÍÁ0.9)mmol£¯L¡¢(5.21Ê¿1.3)mmol£¯L¡¢(2.65¡À1.1)mmol£¯L¡¢(4.01Ê¿1.35)mmol£¯L¡¢(0.99Ê¿0.25)mm£¬µÍÓÚ¶ÔÕÕ×é[(2.59¡À1.2)mmol£¯L¡¢(6.30¡À2.0)mmol£¯L¡¢(3.20¡À1.2)mmol£¯L ¡¢(4.98¡À1.73)mmol£¯L¡¢(1.12¡À0.26)mm£¬(¾ùP<O£®05)¡£
7Â¥2013-10-27 23:32:11
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

befair

Ìú¸Ëľ³æ (ÕýʽдÊÖ)

¡¾´ð°¸¡¿Ó¦Öú»ØÌû

¡ï
ÕæÇ¿±ØÊ¤: ½ð±Ò+1, ¸ø¸öºì°ü£¬Ð»Ð»»ØÌû 2013-12-05 13:55:25
Results: Six months after the treatment, the TG, TC, CH, LDL-C, IMT values are (2.05¡À0.9)mmol£¯L,
(5.21¡À1.3)mmol£¯L, (2.65¡À1.1)mmol£¯L, (4.01¡À1.35)mmol£¯L and (0.99¡À0.25)mm respectively£¬all lower than those of the control group: (2.59¡À1.2)mmol£¯L¡¢(6.30¡À2.0)mmol£¯L¡¢(3.20¡À1.2)mmol£¯L ¡¢(4.98¡À1.73)mmol£¯L¡¢(1.12¡À0.26)mm.
×îºóµÄÒ»¶Î»°£º(¾ùP<O£®05)£¬ÓÐЩÒÉ»ó¡£Êý×ÖÊÇ0.05´ò´íÁËÂ𣿾ùP<ÊÇʲôÒâ˼£¿
Befairorbeaware
8Â¥2013-10-28 07:04:53
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

lovelhw

½ð³æ (³õÈëÎÄ̳)

û´í£¬ÊÇ(¾ùP<O£®05)£¬Ð»Ð»ÁË£¡
9Â¥2013-10-28 21:32:44
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

befair

Ìú¸Ëľ³æ (ÕýʽдÊÖ)

¡¾´ð°¸¡¿Ó¦Öú»ØÌû

¡ï
ÕæÇ¿±ØÊ¤: ½ð±Ò+1 2013-12-08 12:41:47
ÄÇô(¾ùP<O£®05)»¹ÇëÂ¥Ö÷×Ô¼ºÕå×ÃÏ£¬¸öÈ˲²â¿ÉÄܾùP<OÊÇÖ¸ËùÓÐÖÎÁÆ×éÖ¸±ê¾ùµÍÓÚ¶ÔÕÕ×飨P=prescription, O=observation?»¹ÊÇ£¿)£¬Èç¹ûÊÇ¿ÉÒÔ˵all P'values are lower than O's¡£µ«ÎÞÂÛÈçºÎ£¬Àí½â²»Á˺ó±ßµÄ05ÊÇʲôÒâ˼¡£
¼ûÁÂ
Befairorbeaware
10Â¥2013-10-29 07:31:06
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
Ïà¹Ø°æ¿éÌø×ª ÎÒÒª¶©ÔÄÂ¥Ö÷ lovelhw µÄÖ÷Ìâ¸üÐÂ
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[¿¼ÑÐ] ¹ãÎ÷´óѧ²ÄÁϵ¼Ê¦ÍƼö +3 ÏÄÏÄÏÄСÕý 2026-03-17 5/250 2026-03-21 22:20 by ½ðê»ML
[¿¼ÑÐ] 326Çóµ÷¼Á +4 mlpqaz03 2026-03-15 4/200 2026-03-21 19:10 by ColorlessPI
[¿¼ÑÐ] 0703»¯Ñ§µ÷¼Á +4 ÄÝÄÝninicgb 2026-03-21 4/200 2026-03-21 18:39 by ѧԱ8dgXkO
[¿¼ÑÐ] Ò»Ö¾Ô¸Éî´ó£¬0703»¯Ñ§£¬×Ü·Ö302£¬Çóµ÷¼Á +4 ÆßÔÂ-ÆßÆß 2026-03-21 4/200 2026-03-21 18:20 by ѧԱ8dgXkO
[¿¼ÑÐ] 268Çóµ÷¼Á +9 ¼òµ¥µã0 2026-03-17 9/450 2026-03-21 15:37 by lature00
[¿¼ÑÐ] Ò»Ö¾Ô¸»ªÖпƼ¼´óѧ071000£¬Çóµ÷¼Á +3 ÑØ°¶Óб´¿Ç6 2026-03-21 3/150 2026-03-21 10:35 by ÄºÔÆÇ庮
[¿¼ÑÐ] 08¹¤¿Æ 320×Ü·Ö Çóµ÷¼Á +6 À滨çóÍí·ç 2026-03-17 6/300 2026-03-21 03:40 by JourneyLucky
[¿¼ÑÐ] Ò»Ö¾Ô¸ÖйúʯÓÍ´óѧ£¨»ª¶«£© ±¾¿ÆÆë³¹¤Òµ´óѧ +3 ʯÄÜΰ 2026-03-17 3/150 2026-03-21 02:22 by JourneyLucky
[¿¼ÑÐ] ²ÄÁÏרҵÇóµ÷¼Á +6 hanamiko 2026-03-18 6/300 2026-03-21 00:24 by JourneyLucky
[¿¼ÑÐ] 321Çóµ÷¼Á +9 ºÎÈó²É123 2026-03-18 11/550 2026-03-20 23:19 by JourneyLucky
[¿¼ÑÐ] 324Çóµ÷¼Á +5 luckyѽѽѽѼ 2026-03-20 5/250 2026-03-20 22:30 by ´ÙÌì³É
[¿¼ÑÐ] Ò»Ö¾Ô¸ÎäÀí²ÄÁϹ¤³Ì348Çóµ÷¼Á +3 £þ^£þ©bº¹ 2026-03-19 4/200 2026-03-20 21:01 by zhukairuo
[¿¼ÑÐ] Ò»Ö¾Ô¸»ªÖÐũҵ071010£¬×Ü·Ö320Çóµ÷¼Á +3 À§À§À§À§À¤À¤ 2026-03-20 3/150 2026-03-20 20:38 by ѧԱ8dgXkO
[¿¼ÑÐ] 319Çóµ÷¼Á +3 СÁ¦Æøçæçæ 2026-03-20 3/150 2026-03-20 19:47 by JourneyLucky
[¿¼ÑÐ] 281Çóµ÷¼Á£¨0805£© +14 ÑÌÏ«Ò亣 2026-03-16 25/1250 2026-03-20 15:47 by yuncha
[¿¼ÑÐ] 0856µ÷¼Á£¬ÊÇѧУ¾ÍÈ¥ +8 sllhht 2026-03-19 9/450 2026-03-20 14:25 by ÎÞи¿É»÷111
[¿¼ÑÐ] ²ÄÁϹ¤³Ìר˶µ÷¼Á +5 204818@lcx 2026-03-17 6/300 2026-03-18 22:55 by 204818@lcx
[¿¼ÑÐ] ÉúÎïѧ071000 329·ÖÇóµ÷¼Á +3 ÎÒ°®ÉúÎïÉúÎﰮΠ2026-03-17 3/150 2026-03-18 10:12 by macy2011
[¿¼ÑÐ] 277µ÷¼Á +5 ×ÔÓɼå±ý¹û×Ó 2026-03-16 6/300 2026-03-17 19:26 by Àîleezz
[¿¼ÑÐ] 301Çóµ÷¼Á +4 A_JiXing 2026-03-16 4/200 2026-03-17 17:32 by ruiyingmiao
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û